ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Amgen, Genzyme, Thoratec Mourn Loss Of Executives Killed In Plane Hijackings

September 21, 2001

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

June 7, 1991

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980